Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01924260
Recruitment Status : Completed
First Posted : August 16, 2013
Last Update Posted : April 8, 2021
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Takeda
Information provided by (Responsible Party):
Karen Kelly, University of California, Davis

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 8, 2017
Actual Study Completion Date : February 8, 2017